Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. The company leverages a strong distribution and manufacturing infrastructure to serve diverse patient populations across India.
Cyborg Score Rationale
GSK India maintains a leading market position with diversified portfolio spanning general medicines, vaccines, and specialty medicines across respiratory and oncology. However, revenue growth has been modest (5.49% CAGR over five years as of July 2026), and market capitalization has declined significantly, indicating challenges in competitive positioning.
Top Insights
GSK has a head office in Mumbai with a manufacturing facility at Nashik in Maharashtra, 20 Contract Manufacturing Organisations.
The company's product portfolio includes prescription medicines and vaccines.
The company's product portfolio comprises a broad range of General Medicines which includes anti-infectives, pain management, vitamins, minerals, nutritionals, hormones, dermatologicals, vaccines for both children and adults, and specialty medicines for respiratory and oncology.
The company maintains significant distribution reach through 26 warehouses and 6,000 stockists across India as of July 2026.
Named Competitors
Cipla — Leading Indian pharmaceutical company with diversified portfolio
Lupin — Major Indian pharma player with global presence
Aurobindo — Significant player in generic and branded pharmaceuticals
Sun Pharma — Major Indian multinational pharma company
Recent Developments
As of July 2026, GSK India operates with a market capitalization of approximately ₹40,581 crores and revenue of ₹3,822 crores, reflecting modest historical growth patterns.
Open the full interactive GlaxoSmithKline Pharmaceuticals Limited report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.